136 related articles for article (PubMed ID: 18261841)
1. Increased graft content of vascular progenitor cells is associated with reduced toxicity following autologous hematopoietic transplantation.
Iqbal T; Rajagopal T; Halpenny M; Yang L; Martin L; Giulivi A; McDiarmid S; Huebsch L; Allan DS
Exp Hematol; 2008 Apr; 36(4):506-12. PubMed ID: 18261841
[TBL] [Abstract][Full Text] [Related]
2. Increased plasma EPO and MIP-1 alpha are associated with recruitment of vascular progenitors but not CD34(+) cells in autologous peripheral blood stem cell grafts.
Labonté L; Li Y; Yang L; Gillingham A; Halpenny M; Giulivi A; Sills T; Evans K; Zanke B; Allan DS
Exp Hematol; 2009 Jun; 37(6):673-8. PubMed ID: 19463769
[TBL] [Abstract][Full Text] [Related]
3. Endothelial-like vascular progenitor cells (VPCs) from allogeneic and autologous donors: mobilization features distinct from hematopoietic progenitors.
Allan DS; Dubé P; Roy J; Busque L; Roy DC
Biol Blood Marrow Transplant; 2007 Apr; 13(4):433-9. PubMed ID: 17382249
[TBL] [Abstract][Full Text] [Related]
4. Reduced hemoglobin on day of peripheral blood progenitor cell collection is associated with low graft content of vascular progenitors and increased toxicity after autologous hematopoietic stem cell transplantation.
Kasbia G; Al-Gahtani F; Tay J; Labonté L; Tinmouth A; Ramsay T; Gillingham A; Yang L; Halpenny M; Giulivi A; McDiarmid S; Huebsch L; Allan DS
Transfusion; 2008 Nov; 48(11):2421-8. PubMed ID: 18673346
[TBL] [Abstract][Full Text] [Related]
5. CD34(+) hematopoietic progenitor cell selection of bone marrow grafts for autologous transplantation in pediatric patients.
Kasow KA; Sims-Poston L; Eldridge P; Hale GA
Biol Blood Marrow Transplant; 2007 May; 13(5):608-14. PubMed ID: 17448921
[TBL] [Abstract][Full Text] [Related]
6. Mobilization of circulating vascular progenitors in cancer patients receiving external beam radiation in response to tissue injury.
Allan DS; Morgan SC; Birch PE; Yang L; Halpenny MJ; Gunanayagam A; Li Y; Eapen L
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):220-4. PubMed ID: 19695439
[TBL] [Abstract][Full Text] [Related]
7. Effect of CD34 cell dose on hematopoietic reconstitution and outcome in 508 patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation.
Klaus J; Herrmann D; Breitkreutz I; Hegenbart U; Mazitschek U; Egerer G; Cremer FW; Lowenthal RM; Huesing J; Fruehauf S; Moehler T; Ho AD; Goldschmidt H
Eur J Haematol; 2007 Jan; 78(1):21-8. PubMed ID: 17042762
[TBL] [Abstract][Full Text] [Related]
8. Isolation of purified autologous peripheral blood CD34+ cells with low T cell content using CliniMACS device--a local experience.
Leong CF; Habsah A; Teh HS; Goh KY; Fadilah SA; Cheong SK
Malays J Pathol; 2008 Jun; 30(1):31-6. PubMed ID: 19108409
[TBL] [Abstract][Full Text] [Related]
9. Failure to achieve a threshold dose of CD34+CD110+ progenitor cells in the graft predicts delayed platelet engraftment after autologous stem cell transplantation for multiple myeloma.
Wallington-Beddoe CT; Gottlieb DJ; Garvin F; Antonenas V; Sartor MM
Biol Blood Marrow Transplant; 2009 Nov; 15(11):1386-93. PubMed ID: 19822297
[TBL] [Abstract][Full Text] [Related]
10. Fresh PBSC harvests, but not BM, show temperature-related loss of CD34 viability during storage and transport.
Antonenas V; Garvin F; Webb M; Sartor M; Bradstock KF; Gottlieb D
Cytotherapy; 2006; 8(2):158-65. PubMed ID: 16698689
[TBL] [Abstract][Full Text] [Related]
11. Post-thaw viable CD34(+) cell count is a valuable predictor of haematopoietic stem cell engraftment in autologous peripheral blood stem cell transplantation.
Lee S; Kim S; Kim H; Baek EJ; Jin H; Kim J; Kim HO
Vox Sang; 2008 Feb; 94(2):146-52. PubMed ID: 18028260
[TBL] [Abstract][Full Text] [Related]
12. Novel antibodies to the donor stem cell population CD34+/VEGFR-2+ are associated with rejection after hematopoietic stem cell transplantation.
Nordlander A; Mattsson J; Sundberg B; Sumitran-Holgersson S
Transplantation; 2008 Sep; 86(5):686-96. PubMed ID: 18791450
[TBL] [Abstract][Full Text] [Related]
13. Infections after CD34-selected or unmanipulated autologous hematopoietic stem cell transplantation.
Frère P; Pereira M; Fillet G; Beguin Y
Eur J Haematol; 2006 Feb; 76(2):102-8. PubMed ID: 16405430
[TBL] [Abstract][Full Text] [Related]
14. Reduced dose of lenograstim is as efficacious as standard dose of filgrastim for peripheral blood stem cell mobilization and transplantation: a randomized study in patients undergoing autologous peripheral stem cell transplantation.
Ataergin S; Arpaci F; Turan M; Solchaga L; Cetin T; Ozturk M; Ozet A; Komurcu S; Ozturk B
Am J Hematol; 2008 Aug; 83(8):644-8. PubMed ID: 18508321
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor and activin-a serum levels following allogeneic hematopoietic stem cell transplantation.
Nachbaur D; Schumacher P; Auberger J; Clausen J; Kircher B
Biol Blood Marrow Transplant; 2007 Aug; 13(8):942-7. PubMed ID: 17640598
[TBL] [Abstract][Full Text] [Related]
16. The release of soluble factors contributing to endothelial activation and damage after hematopoietic stem cell transplantation is not limited to the allogeneic setting and involves several pathogenic mechanisms.
Palomo M; Diaz-Ricart M; Carbo C; Rovira M; Fernandez-Aviles F; Escolar G; Eissner G; Holler E; Carreras E
Biol Blood Marrow Transplant; 2009 May; 15(5):537-46. PubMed ID: 19361745
[TBL] [Abstract][Full Text] [Related]
17. Comparative assessment of telomere length before and after hematopoietic SCT: role of grafted cells in determining post-transplant telomere status.
Ruella M; Rocci A; Ricca I; Carniti C; Bodoni CL; Ladetto M; Caracciolo D; Boccadoro M; Carlo-Stella C; Corradini P; Tarella C
Bone Marrow Transplant; 2010 Mar; 45(3):505-12. PubMed ID: 19838219
[TBL] [Abstract][Full Text] [Related]
18. [The use of peripheral blood progenitor cells as an autologous hematopoietic support in high-dose chemotherapy. I. The rationale and results].
Silva MR; Passos-Coelho JL; da Costa FL; Machado MA; Miranda N; Miranda MH; Parreira A
Acta Med Port; 1999; 12(7-11):265-73. PubMed ID: 10707464
[TBL] [Abstract][Full Text] [Related]
19. High peripheral blood progenitor cell counts enable autologous backup before stem cell transplantation for malignant infantile osteopetrosis.
Steward CG; Blair A; Moppett J; Clarke E; Virgo P; Lankester A; Burger SR; Sauer MG; Flanagan AM; Pamphilon DH; Orchard PJ
Biol Blood Marrow Transplant; 2005 Feb; 11(2):115-21. PubMed ID: 15682072
[TBL] [Abstract][Full Text] [Related]
20. Failure to achieve a threshold dose of CD34+ CD110+ progenitor cells in the graft predicts delayed platelet engraftment after autologous stem cell transplantation.
Sartor MM; Garvin F; Antonenas V; Bradstock KF; Gottlieb DJ
Bone Marrow Transplant; 2007 Nov; 40(9):851-7. PubMed ID: 17704793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]